Saw Palmetto and Improved AUA Symptom Index

• Treatment assignment guesses by study participants in a double-blind dose escalation clinical trial of saw palmetto.

  • 2014-01
  • RCT · n = 155
  • Journal of alternative and complementary medicine (New York, N.Y.) 20(1)
  • • Jeannette Y Lee
    • Page Moore
    • John Kusek
    • Michael Barry

  • PubMed: 23383975
  • DOI: 10.1089/acm.2012.0284

  1 Insight on

  • Improved AUA Symptom Index

  • High evidence
  • Large Human Trial
  • Clinical

  Participants who experienced an improvement in AUA-SI were 2.16 times more likely to think they were on saw palmetto.

  Effect

  Neutral

  Effect size

  Small

  Significant

  Yes

  Dose

  one 320 mg gelcap daily for the first 24 weeks, two 320 mg gelcaps daily for the second 24 weeks, and three 320 mg gelcaps daily for the third 24 weeks